Annual CFF
$4.64 M
-$10.98 M-70.30%
December 31, 2023
Summary
- As of February 7, 2025, CNSP annual cash flow from financing activities is $4.64 million, with the most recent change of -$10.98 million (-70.30%) on December 31, 2023.
- During the last 3 years, CNSP annual CFF has fallen by -$9.50 million (-67.19%).
- CNSP annual CFF is now -70.30% below its all-time high of $15.61 million, reached on December 31, 2022.
Performance
CNSP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$12.28 M
+$9.95 M+427.85%
September 30, 2024
Summary
- As of February 7, 2025, CNSP quarterly cash flow from financing activities is $12.28 million, with the most recent change of +$9.95 million (+427.85%) on September 30, 2024.
- Over the past year, CNSP quarterly CFF has increased by +$12.27 million (+146109.52%).
- CNSP quarterly CFF is now -13.38% below its all-time high of $14.18 million, reached on December 31, 2020.
Performance
CNSP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$20.24 M
+$12.27 M+153.97%
September 30, 2024
Summary
- As of February 7, 2025, CNSP TTM cash flow from financing activities is $20.24 million, with the most recent change of +$12.27 million (+153.97%) on September 30, 2024.
- Over the past year, CNSP TTM CFF has increased by +$12.45 million (+159.78%).
- CNSP TTM CFF is now at all-time high.
Performance
CNSP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CNSP Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.3% | +10000.0% | +159.8% |
| 3 y3 years | -67.2% | +257.4% | +7.8% |
| 5 y5 years | +299.4% | +257.4% | +7.8% |
CNSP Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.3% | +2.8% | at high | >+9999.0% | at high | +349.0% |
| 5 y | 5-year | -70.3% | +2.8% | -13.4% | >+9999.0% | at high | +349.0% |
| alltime | all time | -70.3% | +299.4% | -13.4% | >+9999.0% | at high | >+9999.0% |
CNS Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.28 M(+427.9%) | $20.24 M(+154.0%) |
| Jun 2024 | - | $2.33 M(-32.7%) | $7.97 M(-3.0%) |
| Mar 2024 | - | $3.46 M(+58.8%) | $8.22 M(+77.2%) |
| Dec 2023 | $4.64 M(-70.3%) | $2.18 M(>+9900.0%) | $4.64 M(-40.5%) |
| Sep 2023 | - | $8400.00(-99.7%) | $7.79 M(+1.6%) |
| Jun 2023 | - | $2.57 M(-2237.6%) | $7.67 M(+54.0%) |
| Mar 2023 | - | -$120.30 K(-102.3%) | $4.98 M(-68.1%) |
| Dec 2022 | $15.61 M(+246.3%) | $5.33 M(-4654.5%) | $15.61 M(+53.1%) |
| Sep 2022 | - | -$117.10 K(+0.8%) | $10.20 M(-25.8%) |
| Jun 2022 | - | -$116.20 K(-101.1%) | $13.75 M(-6.3%) |
| Mar 2022 | - | $10.51 M(<-9900.0%) | $14.67 M(+225.5%) |
| Dec 2021 | $4.51 M | -$82.80 K(-102.4%) | $4.51 M(-76.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $3.44 M(+325.1%) | $18.77 M(+22.8%) |
| Jun 2021 | - | $808.30 K(+132.7%) | $15.29 M(+5.6%) |
| Mar 2021 | - | $347.40 K(-97.5%) | $14.48 M(+2.5%) |
| Dec 2020 | $14.13 M(+37.8%) | $14.18 M(<-9900.0%) | $14.13 M(+60.9%) |
| Sep 2020 | - | -$45.00 K(<-9900.0%) | $8.78 M(-1.6%) |
| Jun 2020 | - | $0.00(0.0%) | $8.93 M(-13.4%) |
| Mar 2020 | - | $0.00(-100.0%) | $10.31 M(+0.5%) |
| Dec 2019 | $10.26 M(+783.7%) | $8.83 M(+9049.3%) | $10.26 M(+617.1%) |
| Sep 2019 | - | $96.50 K(-93.0%) | $1.43 M(+7.2%) |
| Jun 2019 | - | $1.38 M(-2979.6%) | $1.33 M(-2879.6%) |
| Mar 2019 | - | -$48.00 K | -$48.00 K |
| Dec 2018 | $1.16 M | - | - |
FAQ
- What is CNS Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual CFF year-on-year change?
- What is CNS Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly CFF year-on-year change?
- What is CNS Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM CFF year-on-year change?
What is CNS Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of CNSP is $4.64 M
What is the all time high annual CFF for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual cash flow from financing activities is $15.61 M
What is CNS Pharmaceuticals annual CFF year-on-year change?
Over the past year, CNSP annual cash flow from financing activities has changed by -$10.98 M (-70.30%)
What is CNS Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of CNSP is $12.28 M
What is the all time high quarterly CFF for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly cash flow from financing activities is $14.18 M
What is CNS Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, CNSP quarterly cash flow from financing activities has changed by +$12.27 M (+146109.52%)
What is CNS Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of CNSP is $20.24 M
What is the all time high TTM CFF for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM cash flow from financing activities is $20.24 M
What is CNS Pharmaceuticals TTM CFF year-on-year change?
Over the past year, CNSP TTM cash flow from financing activities has changed by +$12.45 M (+159.78%)